In this podcast, listen in as our expert panel debates whether metformin should still be first-line for all patients with type 2 diabetes…and discusses the role of GLP-1 agonists and SGLT2 inhibitors in these patients.
- Provider:TRC Healthcare
- Start Date: 2023-03-01 06:00:00
- End Date: 2023-03-01 06:00:00
- Credit Details: Pharmacy: 0.25 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest